According to the press service of the Institute, Novosibirsk scientists plan to test the hypothesis of their foreign colleagues, who in 2010 discovered in the Arctic Colwellia psychrerythraea - bacteria that contribute to the fight against tuberculosis. The age of the bacteria is multi-story, however, was found only a few years ago.
The representative of the Novosibirsk scientific research Institute, in collaboration with the University of Victoria will hold a series of studies that will confirm or refute the phenomenon of bacterium Colwellia psychrerythraea.
The peculiarity of bacteria is that they can exist only in conditions of excessive cold, when injected into the warmth of the microorganism dies instantly. For other microorganisms bacterium Colwellia psychrerythraea danger is not, however, if they lay in the foundations of drugs against tuberculosis and other diseases, it will be possible to create a vaccine against the disease.
According to the theory of scientists from Canada Francis Nano and Barry Duplantis, when using Colwellia psychrerythraea as architectural bacteria and their subsequent embedding in Mycobacterium tuberculosis they become sensitive to the temperature. That is, if it enters the human organism Mycobacterium tuberculosis die.
Prior to this, Professor B. D. plants created on the basis of Colwellia psychrerythraea thermosensitive drug Francisella tularensis, which has already been tested on laboratory animals. The result showed that increasing the dose of the drug, rodents do not die, but continued to successfully cured. It also became known that in addition to the heat-sensitive Mycobacterium tuberculosis, the Professor has created responsive to heat Salmonella and mycobacteriosis.
After conducting research on animals, scientists will create strains of Mycobacterium tuberculosis specially for a person, taking into account the internal environment of the body. Especially for this Foundation, Grand Challenges Canada has allocated stock funds for advanced research opportunities Colwellia psychrerythraea. The project is international and will bring together scientists from all over the world, including Russia. The representative was of the Novosibirsk Institute of tuberculosis.
The end of the program designed for March 2014.